http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2019577-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a14cc1ad3881d897b18482a3289502 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
filingDate | 1990-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_605725b6baa4b9081661d0412b57e6c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96196139100b6f980341d3749877bcd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26581f4316a7c2794f8aebdd77402474 |
publicationDate | 1991-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2019577-A1 |
titleOfInvention | Imidazo [2,1-b]thiazole compounds and anti-ulcer compositions containing the same |
abstract | ABSTRACT OF THE DISCLOSURE The present invention relates to imidazo[2,1-b]thiazole compounds represented by formula (I) and pharmacologically acceptable salts thereof: (I) wherein R1 and R2 may be the same or different groups and each represents a hydrogen atom or a lower alkyl group having 1 to 6 carbon atoms; R3 represents a hydrogen atom, a lower alkyl group having 1 to 6 carbon atoms or a phenyl group which may be optionally substituted by methyl group, methoxy group or halogen; and R4 represents a hydrogen atom or a lower alkyl group having 1 to 3 carbon atoms, with the proviso that when R3 represents a hydrogen atom, at least one of R1 and R2 represents a lower alkyl group having 1 to 6 carbon atoms, and antiulcer agents comprising said compounds or salts thereof as the active ingredient. |
priorityDate | 1990-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.